NCT01774851 2017-06-22
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
Merrimack Pharmaceuticals
Phase 2 Terminated
Clinical Trials
4 trialsNCT01304784 2015-12-16
A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer
Merrimack Pharmaceuticals
Phase 1 Completed
NCT00911898 2015-01-13
Monotherapy
Merrimack Pharmaceuticals
Phase 1 Completed
NCT01097460 2015-01-07
MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Merrimack Pharmaceuticals
Phase 1 Completed